[go: up one dir, main page]

EP2398761A4 - Libération contrôlée d'oxyde nitrique et de médicaments à parti de macromères et d'oligomères fonctionnalisés - Google Patents

Libération contrôlée d'oxyde nitrique et de médicaments à parti de macromères et d'oligomères fonctionnalisés

Info

Publication number
EP2398761A4
EP2398761A4 EP10744155.2A EP10744155A EP2398761A4 EP 2398761 A4 EP2398761 A4 EP 2398761A4 EP 10744155 A EP10744155 A EP 10744155A EP 2398761 A4 EP2398761 A4 EP 2398761A4
Authority
EP
European Patent Office
Prior art keywords
oligomers
drugs
controlled release
nitric oxide
functionalized macromers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10744155.2A
Other languages
German (de)
English (en)
Other versions
EP2398761A2 (fr
Inventor
Rao S Bezwada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bezwada Biomedical LLC
Original Assignee
Bezwada Biomedical LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/508,854 external-priority patent/US8062653B2/en
Application filed by Bezwada Biomedical LLC filed Critical Bezwada Biomedical LLC
Publication of EP2398761A2 publication Critical patent/EP2398761A2/fr
Publication of EP2398761A4 publication Critical patent/EP2398761A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A61L17/12—Homopolymers or copolymers of glycolic acid or lactic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/14—Post-treatment to improve physical properties
    • A61L17/145—Coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C08G63/6852—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/34—Oligomeric, e.g. cyclic oligomeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
EP10744155.2A 2009-02-18 2010-02-11 Libération contrôlée d'oxyde nitrique et de médicaments à parti de macromères et d'oligomères fonctionnalisés Withdrawn EP2398761A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15334909P 2009-02-18 2009-02-18
US12/508,854 US8062653B2 (en) 2009-02-18 2009-07-24 Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US24943309P 2009-10-07 2009-10-07
PCT/US2010/023845 WO2010096320A2 (fr) 2009-02-18 2010-02-11 Libération contrôlée d'oxyde nitrique et de médicaments à parti de macromères et d'oligomères fonctionnalisés

Publications (2)

Publication Number Publication Date
EP2398761A2 EP2398761A2 (fr) 2011-12-28
EP2398761A4 true EP2398761A4 (fr) 2015-11-04

Family

ID=42634401

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10744155.2A Withdrawn EP2398761A4 (fr) 2009-02-18 2010-02-11 Libération contrôlée d'oxyde nitrique et de médicaments à parti de macromères et d'oligomères fonctionnalisés

Country Status (2)

Country Link
EP (1) EP2398761A4 (fr)
WO (1) WO2010096320A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128121A2 (fr) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Particules liberant de l'oxyde nitrique pour therapie a base d'oxyde nitrique et applications biomedicales
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CN102711729B (zh) 2009-08-21 2015-04-01 诺万公司 局部用凝胶
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (fr) 2011-02-28 2018-08-15 Novan, Inc. Particules de silice modifiées par des groupements s-nitrosothiols libérant de l'oxyde nitrique et procédés de fabrication associés
KR101351130B1 (ko) 2012-11-05 2014-01-15 포항공과대학교 산학협력단 카테콜아민을 이용하여 재료의 표면에 일산화질소 함유 코팅막을 형성하는 방법
CN109937234B (zh) * 2016-10-07 2021-11-26 北卡罗来纳大学教堂山分校 S-亚硝基硫醇介导的超支化聚酯
US11072668B2 (en) 2017-01-03 2021-07-27 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
CA3055474A1 (fr) 2017-03-28 2018-10-04 The University Of North Carolina At Chapel Hill Polyaminoglycosides liberant de l'oxyde nitrique en tant qu'echafaudages antibacteriens biodegradables et procedes associes
CA3091458A1 (fr) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Cyclodextrines liberant de l'oxyde nitrique en tant qu'echafaudages antibacteriens biodegradables et procedes s'y rapportant
MX2021001503A (es) * 2018-08-06 2021-04-28 Nicox Sa Inhibidor de fosfodiesterasa tipo 5 con liberacion de oxido nitrico.
AU2019414421B2 (en) 2018-12-28 2023-08-31 The University Of North Carolina At Chapel Hill Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto
EP3904335A4 (fr) * 2018-12-29 2022-09-14 Jing Zhang Dérivé d'acide acétylsalicylique et son utilisation

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028845A1 (en) * 1999-10-27 2002-03-07 Ekwuribe Nnochiri Nkem 6-methoxy-2-naphthylacetic acid prodrugs
US20030219494A1 (en) * 2002-03-20 2003-11-27 Smith Maree Therese Compositions and methods of using them
WO2004004648A2 (fr) * 2002-07-03 2004-01-15 Nitromed, Inc. Composes anti-inflammatoires non-steroidiens nitroses, compositions et leur procede d'utilisation
US6987120B1 (en) * 1999-04-13 2006-01-17 Nicox, S.A. Pharmaceutical compounds
US20060046967A1 (en) * 2004-08-26 2006-03-02 Apparao Satyam Prodrugs containing novel bio-cleavable linkers
US20060172983A1 (en) * 2005-01-28 2006-08-03 Bezwada Biomedical, Llc Functionalized drugs and polymers derived therefrom
WO2007090733A1 (fr) * 2006-02-06 2007-08-16 Nicox S.A. Dérivés nitrooxy utilisables comme agonistes des récepteurs alpha 2 adrénergiques
CN101053662A (zh) * 2007-04-30 2007-10-17 江苏吴中苏药医药开发有限责任公司 带一氧化氮供体的非甾体抗炎药及其制备方法
WO2007137980A1 (fr) * 2006-05-29 2007-12-06 Nicox S.A. Composés hétérocycliques nitrés en tant qu'antagonistes de récepteur de l'endothéline
US20080221073A1 (en) * 2005-09-02 2008-09-11 Francesca Benedini Nitrooxy Derivatives of Glucocorticoids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262791B (en) * 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987120B1 (en) * 1999-04-13 2006-01-17 Nicox, S.A. Pharmaceutical compounds
US20020028845A1 (en) * 1999-10-27 2002-03-07 Ekwuribe Nnochiri Nkem 6-methoxy-2-naphthylacetic acid prodrugs
US20030219494A1 (en) * 2002-03-20 2003-11-27 Smith Maree Therese Compositions and methods of using them
WO2004004648A2 (fr) * 2002-07-03 2004-01-15 Nitromed, Inc. Composes anti-inflammatoires non-steroidiens nitroses, compositions et leur procede d'utilisation
US20060046967A1 (en) * 2004-08-26 2006-03-02 Apparao Satyam Prodrugs containing novel bio-cleavable linkers
US20060172983A1 (en) * 2005-01-28 2006-08-03 Bezwada Biomedical, Llc Functionalized drugs and polymers derived therefrom
US20080221073A1 (en) * 2005-09-02 2008-09-11 Francesca Benedini Nitrooxy Derivatives of Glucocorticoids
WO2007090733A1 (fr) * 2006-02-06 2007-08-16 Nicox S.A. Dérivés nitrooxy utilisables comme agonistes des récepteurs alpha 2 adrénergiques
WO2007137980A1 (fr) * 2006-05-29 2007-12-06 Nicox S.A. Composés hétérocycliques nitrés en tant qu'antagonistes de récepteur de l'endothéline
CN101053662A (zh) * 2007-04-30 2007-10-17 江苏吴中苏药医药开发有限责任公司 带一氧化氮供体的非甾体抗炎药及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Cellulose Solvents: For Analysis, Shaping and Chemical Modification", vol. 1054, 18 November 2010, AMERICAN CHEMICAL SOCIETY, Washington, DC, ISBN: 978-0-84-120007-4, ISSN: 0097-6156, article RAO S. BEZWADA: "Nitric Oxide and Drug Releasing Hydrolysable Macromers, Oligomers and Polymers", pages: 197 - 220, XP055181889, DOI: 10.1021/bk-2010-1054.ch011 *
ABADI ET AL: "Synthesis and cyclooxygenase inhibitory properties of novel (+) 2-(6-methoxy-2-naphthyl)propanoic acid (naproxen) derivatives", ARCHIV DER PHARMAZIE, WILEY VERLAG, WEINHEIM, vol. 334, no. 3, 1 January 2001 (2001-01-01), pages 104 - 106, XP002267383, ISSN: 0365-6233, DOI: 10.1002/1521-4184(200103)334:3<104::AID-ARDP104>3.3.CO;2-I *
RANATUNGE R R ET AL: "Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: Nitric oxide-donor naproxen prodrugs", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 14, no. 8, 15 April 2006 (2006-04-15), pages 2589 - 2599, XP027992518, ISSN: 0968-0896, [retrieved on 20060415] *

Also Published As

Publication number Publication date
WO2010096320A2 (fr) 2010-08-26
WO2010096320A3 (fr) 2011-02-03
EP2398761A2 (fr) 2011-12-28

Similar Documents

Publication Publication Date Title
EP2398761A4 (fr) Libération contrôlée d&#39;oxyde nitrique et de médicaments à parti de macromères et d&#39;oligomères fonctionnalisés
EP2501427A4 (fr) Système de distribution d&#39;oxyde nitrique
IL216955A0 (en) Medical devices and methods
PL2493698T3 (pl) Urządzenia zabezpieczające i sposoby ich wytwarzania
IL215665A0 (en) Nanoparticle formulations and uses therof
EP2563435A4 (fr) Administration de monoxyde d&#39;azote (no) ultra pur
EP2413917A4 (fr) Système d&#39;administration de médicament et procédés d&#39;utilisation correspondants
EP2412292A4 (fr) Dispositif médical de capsule et système médical de capsule
IL215389A0 (en) Pneumococcal vaccine and uses thereof
PT2421582T (pt) Dispositivo funcional externo, aparelho de tratamento de sangue para receber um dispositivo funcional externo de acordo com a presente invenção, assim como processos
HK1175129A1 (en) Drug delivery devices and method of assembly
EP2445568A4 (fr) Dispositifs médicaux d&#39;administration orientables et procédés d&#39;utilisation
EP2456572A4 (fr) Système d injecteur médical multi-fluides et procédés de fonctionnement
IL219085A0 (en) Solid precursor delivery assemblies and related methods
EP2408770A4 (fr) Benzothiophène-nitrothiazolide à spectre large et autres antimicrobiens
IL217119A0 (en) Systems and devices for performing gastrointestinal procedures
EP2464652A4 (fr) Précurseurs contenant de l&#39;hafnium et du zirconium et procédés pour leur utilisation
GB2467910B (en) Combination of mechanical actuator and case cooling apparatus
GB2467777B (en) MEMS device and process
IL219155A0 (en) Pharmaceutical formulations of nitrite and uses thereof
EP2473474A4 (fr) Diesters aromatiques fonctionnalisés de fluoroéther et dérivés de ceux-ci
EP2408511A4 (fr) Appareil d&#39;administration de médicaments solides, préparations et procédés d&#39;utilisation
GB0907972D0 (en) Payload handling apparatus and system
GB0920113D0 (en) Anti-bacterial treatment and device
GB0921663D0 (en) Safety device and arrangement

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110915

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/00 20060101ALI20150429BHEP

Ipc: C07C 233/31 20060101ALI20150429BHEP

Ipc: A61L 17/00 20060101ALI20150429BHEP

Ipc: A61L 31/16 20060101ALI20150429BHEP

Ipc: A61K 47/48 20060101ALI20150429BHEP

Ipc: A61K 47/16 20060101ALI20150429BHEP

Ipc: A61L 17/12 20060101ALI20150429BHEP

Ipc: C07C 233/25 20060101ALI20150429BHEP

Ipc: C07C 235/16 20060101ALI20150429BHEP

Ipc: A61P 35/00 20060101ALI20150429BHEP

Ipc: C08G 63/685 20060101ALI20150429BHEP

Ipc: A61L 27/14 20060101ALI20150429BHEP

Ipc: C07C 235/12 20060101ALI20150429BHEP

Ipc: A61L 31/14 20060101ALI20150429BHEP

Ipc: A61L 31/10 20060101ALI20150429BHEP

Ipc: C07C 203/04 20060101AFI20150429BHEP

Ipc: C07C 233/33 20060101ALI20150429BHEP

Ipc: A61L 17/14 20060101ALI20150429BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20151005

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 235/16 20060101ALI20150929BHEP

Ipc: C08G 63/685 20060101ALI20150929BHEP

Ipc: C07C 233/33 20060101ALI20150929BHEP

Ipc: A61L 17/12 20060101ALI20150929BHEP

Ipc: C07C 235/12 20060101ALI20150929BHEP

Ipc: A61L 17/14 20060101ALI20150929BHEP

Ipc: A61P 25/00 20060101ALI20150929BHEP

Ipc: A61L 31/10 20060101ALI20150929BHEP

Ipc: C07C 233/31 20060101ALI20150929BHEP

Ipc: A61P 35/00 20060101ALI20150929BHEP

Ipc: A61L 17/00 20060101ALI20150929BHEP

Ipc: A61L 31/14 20060101ALI20150929BHEP

Ipc: C07C 203/04 20060101AFI20150929BHEP

Ipc: A61L 27/14 20060101ALI20150929BHEP

Ipc: A61L 31/16 20060101ALI20150929BHEP

Ipc: A61K 47/16 20060101ALI20150929BHEP

Ipc: C07C 233/25 20060101ALI20150929BHEP

Ipc: A61K 47/48 20060101ALI20150929BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160503